A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma

NCT02738489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: SHR-1210

Sponsor

Jiangsu HengRui Medicine Co., Ltd.